The 4 things 1 ASC is struggling to keep in stock

Since the COVID-19 pandemic, practices have faced a myriad of supply challenges, from rising costs to persistent shortages. 

Advertisement

The federal government has even stepped in to improve the medical supply chain, enacting Title III of the Defense Production Act, which was first introduced in 1950 during the Cold War to bolster research, development, production and scaling of essential supplies. 

But even with federal and statewide efforts, ASCs are struggling to contend with ongoing recalls, shortages and supply hiccups. 

Jessica Huckins, administrator at Northeast Wyoming Surgery Center in Gillette, told Becker’s the top four things her ASC is struggling to keep in stock. 

Jessica Huckins: We have had difficulty with certain items and medications. 

Among the top are: 

             Sterile tourniquets

             Clindamycin

             Tranexamic acid

             Ketamine

Pricing is also a concern. Supply costs have gone up significantly, while reimbursement has remained stagnant.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.